Distinguishing Molecular Signatures in Early-onset Pancreatic Adenocarcinomas

Cancer shared this article with you from Inoreader Age is in the Eye of the Beholder: Distinguishing Molecular Signatures in Early-onset Pancreatic Adenocarcinomas Via Clinical Cancer Research recent ... Pancreatic ductal adenocarcinoma (PDAC) is more prevalent in older patients, but early-onset cases (<55 years) may be a distinct genetic subpopulation. Differential expression of CDKN2A and transcription factor FOXC2 were found in early-onset cases. This finding opens the door to investigating additional features that distinguish PDAC tumors in this age group. See related article by Tsang et al., p. 246 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.